These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6138783

  • 1. Pharmacology of mesocortical dopamine neurons.
    Bannon MJ, Roth RH.
    Pharmacol Rev; 1983 Mar; 35(1):53-68. PubMed ID: 6138783
    [Abstract] [Full Text] [Related]

  • 2. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 3. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY, Huang M.
    Prog Brain Res; 2008 Mar; 172():177-97. PubMed ID: 18772033
    [Abstract] [Full Text] [Related]

  • 4. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
    Wolf ME, Galloway MP, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
    [Abstract] [Full Text] [Related]

  • 5. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 6. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
    Maćkowiak M, Czyrak A, Wedzony K.
    Psychiatr Pol; 2000 Sep; 34(4):607-21. PubMed ID: 11059260
    [Abstract] [Full Text] [Related]

  • 7. The dopamine systems in the brain, functional classification of different dopamine receptors.
    Ljungberg T.
    Acta Psychiatr Belg; 1987 Sep; 87(5):523-34. PubMed ID: 2897758
    [Abstract] [Full Text] [Related]

  • 8. The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
    Seamans JK, Yang CR.
    Prog Neurobiol; 2004 Sep; 74(1):1-58. PubMed ID: 15381316
    [Abstract] [Full Text] [Related]

  • 9. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals.
    Cubeddu LX, Hoffmann IS, Talmaciu RK.
    Ann N Y Acad Sci; 1990 Sep; 604():452-61. PubMed ID: 2171402
    [Abstract] [Full Text] [Related]

  • 10. The search for selective dopaminergic autoreceptor agonists.
    Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JL.
    J Neural Transm Suppl; 1983 Sep; 18():131-7. PubMed ID: 6576112
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices.
    Bannon MJ, Wolf ME, Roth RH.
    Eur J Pharmacol; 1983 Aug 19; 92(1-2):119-25. PubMed ID: 6628534
    [Abstract] [Full Text] [Related]

  • 12. Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices.
    Altar CA, Boyar WC, Oei E, Wood PL.
    J Pharmacol Exp Ther; 1987 Jul 19; 242(1):115-20. PubMed ID: 3612520
    [Abstract] [Full Text] [Related]

  • 13. Preferential activation of cortical dopamine neurotransmission by clozapine: functional significance.
    Moghaddam B.
    J Clin Psychiatry; 1994 Sep 19; 55 Suppl B():27-9. PubMed ID: 7961567
    [Abstract] [Full Text] [Related]

  • 14. Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.
    Tanda G, Ebbs A, Newman AH, Katz JL.
    J Pharmacol Exp Ther; 2005 May 19; 313(2):613-20. PubMed ID: 15681658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
    Kilts CD, Anderson CM, Ely TD, Nishita JK.
    J Neurosci; 1987 Dec 19; 7(12):3961-75. PubMed ID: 3121804
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A, Lejeune F, Rivet JM, Audinot V, Newman-Tancredi A, Millan MJ.
    J Pharmacol Exp Ther; 1995 Jun 19; 273(3):1032-46. PubMed ID: 7791073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dopamine neuron membrane physiology: characterization of the transient outward current (IA) and demonstration of a common signal transduction pathway for IA and IK.
    Liu L, Shen RY, Kapatos G, Chiodo LA.
    Synapse; 1994 Aug 19; 17(4):230-40. PubMed ID: 7992198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.